Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Glaxosmithkline plc crawled time : 18:00 save search
Press Release: Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors
Published: 2024-02-22 (Crawled : 18:00) - globenewswire.com
ALSMY | News | $1.63 430K
|
Manufacturing
|
| O: 0.0%
H: 0.56%
C: 0.0%
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: 0.45%
H: 0.24%
C: -0.31%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 0.97%
H: 0.0%
C: 0.0%
Vertigo Drugs Market Research Report 2023 - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2018-2028F
Published: 2024-02-01 (Crawled : 18:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K
|
n/a
|
| O: -83.33%
H: 500.0%
C: 500.0%
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: -0.7%
H: 0.0%
C: 0.0%
NVS | News | $98.31 1.06% 1.6M
|
Health Technology
|
| O: -0.5%
H: 0.26%
C: -1.03%
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: -0.05%
H: 0.59%
C: 0.27%
report research global market
Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: 5.68%
H: 0.77%
C: 0.77%
AZNCF | News | $140.3 1.5K
|
Health Technology
|
| O: 3.41%
H: 0.0%
C: -2.45%
VTRS | News A | $11.485 1.1% 2.4M
|
Health Technology
|
| O: -0.08%
H: 3.47%
C: -0.25%
NVS | News | $98.31 1.06% 1.6M
|
Health Technology
|
| O: -2.04%
H: 0.19%
C: -1.97%
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: 4.04%
H: 1.57%
C: -3.02%
ABBV | News | $168.055 -0.88% 1.8M
|
Health Technology
|
| O: 0.5%
H: 0.07%
C: -0.81%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 1.75%
H: 0.0%
C: 0.0%
PBYI | $4.845 -5.56% 200K
|
Health Technology
|
| O: -0.1%
H: 2.31%
C: -1.26%
AZN | News | $71.05 0.28% 4.4M
|
Health Technology
|
| O: 0.82%
H: 0.12%
C: -1.64%
AMGN | News | $273.925 0.14% 1.2M
|
Health Technology
|
| O: 0.44%
H: 0.2%
C: -0.55%
drug breast expected cancer pipeline therapeutics growth market
Kidney Transplantation Therapeutics Market 2023; USD 643.15 million Growth Expected between 2023 and 2028, Rising prevalence of CKD and renal impairments to boost growth - Technavio
Published: 2024-01-29 (Crawled : 18:00) - prnewswire.com
ALPMF | News | $9.5 1.2K
|
Health Technology
|
| O: 1.76%
H: 0.0%
C: 0.0%
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: 2.93%
H: 0.0%
C: -1.15%
ALPMY | News | $9.49 480K
|
Manufacturing
|
| O: -3.53%
H: 3.49%
C: 3.4%
NVS | News | $98.31 1.06% 1.6M
|
Health Technology
|
| O: -0.59%
H: 0.49%
C: 0.41%
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: 0.26%
H: 0.13%
C: -0.18%
ABBV | News | $168.055 -0.88% 1.8M
|
Health Technology
|
| O: 0.19%
H: 0.46%
C: 0.43%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
kidney renal expected million therapeutics growth market
Global Myasthenia Gravis Treatment Market Report 2023 - Opportunities in Tailored Treatment Approaches, Biologics and Immunotherapies and Patient-Centric Care
Published: 2023-12-06 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: 1.64%
H: 0.0%
C: -1.33%
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -2.77%
H: 0.49%
C: 0.49%
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: -0.03%
H: 0.28%
C: -0.41%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
report treatment care global market
Rheumatoid Arthritis Drugs Market to grow by USD 16.04 billion from 2023 to 2028; North America to account for 39% of market growth- Technavio
Published: 2023-12-04 (Crawled : 18:00) - prnewswire.com
ALPMF | News | $9.5 1.2K
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: -2.6%
H: 1.1%
C: -1.18%
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.27%
H: 0.12%
C: 0.12%
NVSEF | News | $96.0 52K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
ALPMY | News | $9.49 480K
|
Manufacturing
|
| O: 0.0%
H: 0.5%
C: 0.17%
NVS | News | $98.31 1.06% 1.6M
|
Health Technology
|
| O: -1.86%
H: 0.34%
C: -0.19%
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: -1.01%
H: 0.39%
C: 0.19%
ABBV | News | $168.055 -0.88% 1.8M
|
Health Technology
|
| O: 0.51%
H: 0.68%
C: 0.32%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
GLMD | $0.373 3.21% 47K
|
Health Technology
|
| O: 0.03%
H: 2.44%
C: -1.03%
AMGN | News | $273.925 0.14% 1.2M
|
Health Technology
|
| O: -0.25%
H: 0.05%
C: -0.37%
america market
GSK Announces AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Is Now Available at All Major US Retail Pharmacies
Published: 2023-08-17 (Crawled : 18:00) - biospace.com/
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: -0.83%
H: 0.62%
C: 0.29%
AGEN A | $7.47 15.63% 980K
|
Health Technology
|
| O: 0.0%
H: 6.35%
C: 4.76%
retail respiratory virus
Arrowhead Pharmaceuticals Announces $30 Million Milestone Payment from GSK
Published: 2023-04-03 (Crawled : 18:00) - biospace.com/
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: 0.11%
H: 0.95%
C: 0.93%
ARWR | $23.215 -2.38% 320K
|
Health Technology
|
| O: -0.08%
H: 1.89%
C: 0.71%
payment pharmaceuticals milestone
GSK and SCYNEXIS Announce an Exclusive Agreement to Commercialise and Further Develop Brexafemme (ibrexafungerp), a Novel, First-in-Class Medicine to Treat Fungal Infection
Published: 2023-03-30 (Crawled : 18:00) - biospace.com/
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: 0.0%
H: 0.65%
C: 0.6%
SPRO | $1.445 0.7% 58K
|
Health Technology
|
| O: 2.07%
H: 0.0%
C: -2.7%
SCYX | $1.52 -1.93% 65K
|
Health Technology
|
| O: 71.86%
H: 3.48%
C: 2.44%
infection agreement brexafemme fungal infection
Antacids Global Market Report 2023
Published: 2023-02-20 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $19.54 2.6K
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $71.05 0.28% 4.4M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $140.3 1.5K
|
Health Technology
| Email alert
Add to watchlist
TAK | News | $13.265 -0.86% 540K
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $106.74 -0.79% 3.3M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
| Email alert
Add to watchlist
global report market
Worldwide Monoclonal Antibodies Industry to 2033 - Rising mAb Therapy Applications for Targeted Therapies Drives Growth
Published: 2023-01-18 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: -1.68%
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -2.5%
H: 0.0%
C: 0.0%
AZNCF | News | $140.3 1.5K
|
Health Technology
|
| O: -1.16%
H: 1.62%
C: -0.54%
NVSEF | News | $96.0 52K
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
VTRS | News A | $11.485 1.1% 2.4M
|
Health Technology
|
| O: -0.17%
H: 0.25%
C: -2.96%
TMO | News | $576.13 0.27% 1.1M
|
Health Technology
|
| O: 0.56%
H: 0.97%
C: -1.87%
NVO | News | $126.19 -1.91% 2.6M
|
Health Technology
|
| O: 0.57%
H: 0.84%
C: -0.01%
NVS | News | $98.31 1.06% 1.6M
|
Health Technology
|
| O: 0.93%
H: 0.01%
C: -1.16%
JNJ | News | $148.66 -0.6% 5.2M
|
Health Technology
|
| O: -0.41%
H: 0.2%
C: -1.1%
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: -0.03%
H: 0.17%
C: -1.01%
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: -0.4%
H: 0.75%
C: -1.21%
ABT | News | $106.74 -0.79% 3.3M
|
Health Technology
|
| O: -0.16%
H: 0.33%
C: -1.5%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
BIIB | $199.93 3.49% 2.2M
|
Health Technology
|
| O: 0.34%
H: 0.46%
C: -2.45%
AZN | News | $71.05 0.28% 4.4M
|
Health Technology
|
| O: 1.36%
H: 0.33%
C: -1.13%
AMGN | News | $273.925 0.14% 1.2M
|
Health Technology
|
| O: 0.0%
H: 0.41%
C: -1.87%
therapy growth
Cancer Monoclonal Antibodies Market Report 2022: Rising Preference for Personalized Medicines Provides Boost to Sector
Published: 2022-11-04 (Crawled : 18:00) - prnewswire.com
GNMSF | News | $290.34 340
|
Health Technology
|
| O: -2.57%
H: 3.43%
C: 2.04%
NVSEF | News | $96.0 52K
|
Health Technology
|
| O: 2.28%
H: 0.0%
C: 0.0%
NVS | News | $98.31 1.06% 1.6M
|
Health Technology
|
| O: 1.13%
H: 0.63%
C: 0.53%
JNJ | News | $148.66 -0.6% 5.2M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: 0.0%
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: 1.25%
H: 0.03%
C: -0.78%
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: 0.97%
H: 0.18%
C: -2.13%
BMY | $48.875 -0.24% 11M
|
Health Technology
|
| O: 0.42%
H: 0.59%
C: -0.04%
ABBV | News | $168.055 -0.88% 1.8M
|
Health Technology
|
| O: 0.64%
H: 0.16%
C: -0.05%
GMAB | News | $28.46 -0.35% 310K
|
Health Technology
|
| O: 0.58%
H: 0.93%
C: 0.93%
AMGN | News | $273.925 0.14% 1.2M
|
Health Technology
|
| O: -1.48%
H: 2.81%
C: 2.71%
report cancer market
This Pharmaceutical Company Is Moving Beyond CBD
Published: 2022-09-14 (Crawled : 18:00) - jupiterwellnessinc.com
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: -4.98%
H: 7.63%
C: 2.67%
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 3.43%
H: 0.0%
C: 0.0%
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: -0.6%
H: 0.41%
C: -0.76%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
JAZZ | $108.08 -1.45% 220K
|
Health Technology
|
| O: 0.13%
H: 0.59%
C: 0.13%
cbd
Global Chronic Obstructive Pulmonary Disease Treatment Market to Surpass US$ 25,601.45 Million by 2030 - Coherent Market Insights
Published: 2022-09-08 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: 2.63%
H: 0.0%
C: -3.84%
AZNCF | News | $140.3 1.5K
|
Health Technology
|
| O: 6.1%
H: 0.13%
C: -1.44%
NVSEF | News | $96.0 52K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -1.42%
NVS | News | $98.31 1.06% 1.6M
|
Health Technology
|
| O: -0.75%
H: 1.17%
C: 1.16%
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: -1.84%
H: 2.04%
C: 1.94%
AZN | News | $71.05 0.28% 4.4M
|
Health Technology
|
| O: -0.47%
H: 1.85%
C: 1.31%
treatment global disease market
Global Osteoarthritis Drugs Market to surpass US$ 16,184.9 million by 2030 - Coherent Market Insights
Published: 2022-09-05 (Crawled : 18:00) - prnewswire.com
NVSEF | News | $96.0 52K
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
| Email alert
Add to watchlist
RDUS | $17.73 0.51% 140K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $148.66 -0.6% 5.2M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $94.25 480
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $98.31 1.06% 1.6M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $19.54 2.6K
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.765 -1.94% 950K
|
Health Technology
| Email alert
Add to watchlist
AVNS | $18.63 -0.69% 74K
|
Health Technology
| Email alert
Add to watchlist
PFE | News 4 | $26.25 -0.27% 12M
|
Health Technology
| Email alert
Add to watchlist
osteoarthritis global market
Global Calcium Channel Blocker Drugs Market to Surpass US$ 21,489.7 Million by 2030 - Coherent Market Insights
Published: 2022-08-23 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: -1.69%
H: 0.0%
C: 0.0%
NVS | News | $98.31 1.06% 1.6M
|
Health Technology
|
| O: -0.91%
H: 0.1%
C: -0.17%
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: -0.88%
H: 0.3%
C: -0.06%
global market
Global Topical Drug Delivery Market Report to 2027 - Featuring Nestle, GlaxoSmithKline and Novartis Among Others
Published: 2022-07-25 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVSEF | News | $96.0 52K
|
Health Technology
|
| O: 3.12%
H: 0.06%
C: 0.06%
TARO | $42.18 -0.12% 6K
|
Health Technology
|
| O: 0.08%
H: 3.37%
C: -1.86%
NVS | News | $98.31 1.06% 1.6M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: 0.19%
JNJ | News | $148.66 -0.6% 5.2M
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: 0.0%
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: 0.76%
H: 0.19%
C: -1.06%
drug global report novartis market
Global Asthma and COPD Drugs Market Report to 2030 - Opportunity Analysis and Industry Forecasts
Published: 2022-05-05 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: 0.18%
H: 0.46%
C: 0.46%
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 1.98%
H: 0.0%
C: -2.72%
AZNCF | News | $140.3 1.5K
|
Health Technology
|
| O: -0.86%
H: 1.57%
C: -0.42%
NVS | News | $98.31 1.06% 1.6M
|
Health Technology
|
| O: -0.39%
H: 0.15%
C: -1.07%
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: -0.98%
H: 0.0%
C: 0.0%
ABT | News | $106.74 -0.79% 3.3M
|
Health Technology
|
| O: -0.73%
H: 0.12%
C: -1.61%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
AZN | News | $71.05 0.28% 4.4M
|
Health Technology
|
| O: -1.35%
H: 0.4%
C: -1.2%
report market drug
Global Biologics Market Analysis Report 2022-2025 & 2030 Featuring Merck & Co, AbbVie, F. Hoffmann-La Roche, Johnson & Johnson, & Pfizer
Published: 2022-04-21 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: 4.04%
H: 0.0%
C: -2.18%
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.07%
H: 0.08%
C: -1.12%
JNJ | News | $148.66 -0.6% 5.2M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: -0.2%
H: 0.0%
C: 0.0%
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
ABBV | News | $168.055 -0.88% 1.8M
|
Health Technology
|
| O: 0.44%
H: 0.0%
C: 0.0%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 2.02%
H: 0.0%
C: 0.0%
AMGN | News | $273.925 0.14% 1.2M
|
Health Technology
|
| O: 0.81%
H: 0.0%
C: 0.0%
report market
ViiV Healthcare Announces US FDA Approval of Cabenuva (cabotegravir, rilpivirine) for Virologically Suppressed Adolescents Living With HIV Who Are 12 Years of Age or Older and Weigh at Least 35 kg
Published: 2022-03-29 (Crawled : 18:00) - biospace.com/
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: -1.87%
PFE | News 4 | $26.25 -0.27% 12M
|
Health Technology
|
| O: 1.35%
H: 0.15%
C: -2.33%
JNJ | News | $148.66 -0.6% 5.2M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
GSK | News | $40.835 -0.98% 1.1M
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
fda approval hiv order
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CSSE 4 | $0.3831 151.54% 190M
|
Consumer Services
CZOO | $11.04 121.24% 11M
|
LICN | $0.9107 62.63% 14M
|
BOF | $1.87 59.83% 100M
|
AMST | $3.18 59.0% 67M
|
Technology Services
MTC | $3.31 47.77% 7.7M
|
Technology Services
MULN | News | $3.915 43.41% 12M
|
Information
WIMI | $1.04 43.37% 17M
|
Technology Services
SKIL 4 | $8.045 40.89% 230K
|
Information
RILY | $30.01 38.17% 11M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.